159 related articles for article (PubMed ID: 16387324)
1. Blood-brain barrier penetration and pharmacokinetics of amitriptyline and its metabolites in p-glycoprotein (abcb1ab) knock-out mice and controls.
Uhr M; Grauer MT; Yassouridis A; Ebinger M
J Psychiatr Res; 2007; 41(1-2):179-88. PubMed ID: 16387324
[TBL] [Abstract][Full Text] [Related]
2. P-glycoprotein reduces the ability of amitriptyline metabolites to cross the blood brain barrier in mice after a 10-day administration of amitriptyline.
Grauer MT; Uhr M
J Psychopharmacol; 2004 Mar; 18(1):66-74. PubMed ID: 15107187
[TBL] [Abstract][Full Text] [Related]
3. Differential enhancement of antidepressant penetration into the brain in mice with abcb1ab (mdr1ab) P-glycoprotein gene disruption.
Uhr M; Grauer MT; Holsboer F
Biol Psychiatry; 2003 Oct; 54(8):840-6. PubMed ID: 14550684
[TBL] [Abstract][Full Text] [Related]
4. Penetration of amitriptyline, but not of fluoxetine, into brain is enhanced in mice with blood-brain barrier deficiency due to mdr1a P-glycoprotein gene disruption.
Uhr M; Steckler T; Yassouridis A; Holsboer F
Neuropsychopharmacology; 2000 Apr; 22(4):380-7. PubMed ID: 10700657
[TBL] [Abstract][Full Text] [Related]
5. abcb1ab P-glycoprotein is involved in the uptake of citalopram and trimipramine into the brain of mice.
Uhr M; Grauer MT
J Psychiatr Res; 2003; 37(3):179-85. PubMed ID: 12650738
[TBL] [Abstract][Full Text] [Related]
6. abcb1ab p-glycoprotein is involved in the uptake of the novel antidepressant vortioxetine into the brain of mice.
Spieler D; Namendorf C; Namendorf T; Uhr M
J Psychiatr Res; 2019 Feb; 109():48-51. PubMed ID: 30476727
[TBL] [Abstract][Full Text] [Related]
7. Influence of efflux transporters on liver, bile and brain disposition of amitriptyline in mice.
Abaut AY; Chevanne F; Le Corre P
Int J Pharm; 2009 Aug; 378(1-2):80-5. PubMed ID: 19508886
[TBL] [Abstract][Full Text] [Related]
8. Donepezil, a cholinesterase inhibitor used in Alzheimer's disease therapy, is actively exported out of the brain by abcb1ab p-glycoproteins in mice.
Spieler D; Namendorf C; Namendorf T; von Cube M; Uhr M
J Psychiatr Res; 2020 May; 124():29-33. PubMed ID: 32114029
[TBL] [Abstract][Full Text] [Related]
9. Dexamethasone changes the pharmacokinetics of amitriptyline and reduces its accumulation in rat brain: The roles of P-gp and cyp3a2.
Wen J; Shen Y; Zhang M; Wang C; Xiang Y; Cai H; Fang P; Li H
J Pharmacol Sci; 2019 May; 140(1):54-61. PubMed ID: 31105024
[TBL] [Abstract][Full Text] [Related]
10. Efavirenz does not interact with the ABCB1 transporter at the blood-brain barrier.
Dirson G; Fernandez C; Hindlet P; Roux F; German-Fattal M; Gimenez F; Farinotti R
Pharm Res; 2006 Jul; 23(7):1525-32. PubMed ID: 16779703
[TBL] [Abstract][Full Text] [Related]
11. Blood-brain barrier penetration of the enantiomers of venlafaxine and its metabolites in mice lacking P-glycoprotein.
Karlsson L; Schmitt U; Josefsson M; Carlsson B; Ahlner J; Bengtsson F; Kugelberg FC; Hiemke C
Eur Neuropsychopharmacol; 2010 Sep; 20(9):632-40. PubMed ID: 20466523
[TBL] [Abstract][Full Text] [Related]
12. Changes in dipole membrane potential at the mouse blood-brain barrier enhance the transport of 99mTechnetium Sestamibi more than inhibiting Abcb1, Abcc1, or Abcg2.
Cattelotte J; Tournier N; Rizzo-Padoin N; Schinkel AH; Scherrmann JM; Cisternino S
J Neurochem; 2009 Feb; 108(3):767-75. PubMed ID: 19067785
[TBL] [Abstract][Full Text] [Related]
13. The role of the polymorphic efflux transporter P-glycoprotein on the brain accumulation of d-methylphenidate and d-amphetamine.
Zhu HJ; Wang JS; DeVane CL; Williard RL; Donovan JL; Middaugh LD; Gibson BB; Patrick KS; Markowitz JS
Drug Metab Dispos; 2006 Jul; 34(7):1116-21. PubMed ID: 16621932
[TBL] [Abstract][Full Text] [Related]
14. Lysophosphatidic acid and amitriptyline signal through LPA1R to reduce P-glycoprotein transport at the blood-brain barrier.
Banks DB; Chan GN; Evans RA; Miller DS; Cannon RE
J Cereb Blood Flow Metab; 2018 May; 38(5):857-868. PubMed ID: 28447863
[TBL] [Abstract][Full Text] [Related]
15. Effects on enantiomeric drug disposition and open-field behavior after chronic treatment with venlafaxine in the P-glycoprotein knockout mice model.
Karlsson L; Hiemke C; Carlsson B; Josefsson M; Ahlner J; Bengtsson F; Schmitt U; Kugelberg FC
Psychopharmacology (Berl); 2011 May; 215(2):367-77. PubMed ID: 21191569
[TBL] [Abstract][Full Text] [Related]
16. Kinetic analysis of the cooperation of P-glycoprotein (P-gp/Abcb1) and breast cancer resistance protein (Bcrp/Abcg2) in limiting the brain and testis penetration of erlotinib, flavopiridol, and mitoxantrone.
Kodaira H; Kusuhara H; Ushiki J; Fuse E; Sugiyama Y
J Pharmacol Exp Ther; 2010 Jun; 333(3):788-96. PubMed ID: 20304939
[TBL] [Abstract][Full Text] [Related]
17. Influence of breast cancer resistance protein (Abcg2) and p-glycoprotein (Abcb1a) on the transport of imatinib mesylate (Gleevec) across the mouse blood-brain barrier.
Bihorel S; Camenisch G; Lemaire M; Scherrmann JM
J Neurochem; 2007 Sep; 102(6):1749-1757. PubMed ID: 17696988
[TBL] [Abstract][Full Text] [Related]
18. Evidence for an active transport of morphine-6-beta-d-glucuronide but not P-glycoprotein-mediated at the blood-brain barrier.
Bourasset F; Cisternino S; Temsamani J; Scherrmann JM
J Neurochem; 2003 Sep; 86(6):1564-7. PubMed ID: 12950465
[TBL] [Abstract][Full Text] [Related]
19. Central nervous system pharmacokinetics of the Mdr1 P-glycoprotein substrate CP-615,003: intersite differences and implications for human receptor occupancy projections from cerebrospinal fluid exposures.
Venkatakrishnan K; Tseng E; Nelson FR; Rollema H; French JL; Kaplan IV; Horner WE; Gibbs MA
Drug Metab Dispos; 2007 Aug; 35(8):1341-9. PubMed ID: 17470526
[TBL] [Abstract][Full Text] [Related]
20. PET-CT imaging with [(18)F]-gefitinib to measure Abcb1a/1b (P-gp) and Abcg2 (Bcrp1) mediated drug-drug interactions at the murine blood-brain barrier.
Vlaming ML; Läppchen T; Jansen HT; Kivits S; van Driel A; van de Steeg E; van der Hoorn JW; Sio CF; Steinbach OC; DeGroot J
Nucl Med Biol; 2015 Nov; 42(11):833-41. PubMed ID: 26264927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]